GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulsion Medical Systems SE (LTS:0NFX) » Definitions » ROE %

Pulsion Medical Systems SE (LTS:0NFX) ROE % : 4.28% (As of Dec. 2022)


View and export this data going back to . Start your Free Trial

What is Pulsion Medical Systems SE ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Pulsion Medical Systems SE's annualized net income for the quarter that ended in Dec. 2022 was €0.99 Mil. Pulsion Medical Systems SE's average Total Stockholders Equity over the quarter that ended in Dec. 2022 was €23.06 Mil. Therefore, Pulsion Medical Systems SE's annualized ROE % for the quarter that ended in Dec. 2022 was 4.28%.

The historical rank and industry rank for Pulsion Medical Systems SE's ROE % or its related term are showing as below:

LTS:0NFX' s ROE % Range Over the Past 10 Years
Min: 0.57   Med: 4.58   Max: 42.88
Current: 4.28

During the past 13 years, Pulsion Medical Systems SE's highest ROE % was 42.88%. The lowest was 0.57%. And the median was 4.58%.

LTS:0NFX's ROE % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -0.54 vs LTS:0NFX: 4.28

Pulsion Medical Systems SE ROE % Historical Data

The historical data trend for Pulsion Medical Systems SE's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulsion Medical Systems SE ROE % Chart

Pulsion Medical Systems SE Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 3.67 0.57 4.87 4.28

Pulsion Medical Systems SE Semi-Annual Data
Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 3.67 0.57 4.87 4.28

Competitive Comparison of Pulsion Medical Systems SE's ROE %

For the Medical Devices subindustry, Pulsion Medical Systems SE's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pulsion Medical Systems SE's ROE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pulsion Medical Systems SE's ROE % distribution charts can be found below:

* The bar in red indicates where Pulsion Medical Systems SE's ROE % falls into.



Pulsion Medical Systems SE ROE % Calculation

Pulsion Medical Systems SE's annualized ROE % for the fiscal year that ended in Dec. 2022 is calculated as

ROE %=Net Income (A: Dec. 2022 )/( (Total Stockholders Equity (A: Dec. 2021 )+Total Stockholders Equity (A: Dec. 2022 ))/ count )
=0.988/( (22.568+23.556)/ 2 )
=0.988/23.062
=4.28 %

Pulsion Medical Systems SE's annualized ROE % for the quarter that ended in Dec. 2022 is calculated as

ROE %=Net Income (Q: Dec. 2022 )/( (Total Stockholders Equity (Q: Dec. 2021 )+Total Stockholders Equity (Q: Dec. 2022 ))/ count )
=0.988/( (22.568+23.556)/ 2 )
=0.988/23.062
=4.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (Dec. 2022) net income data. ROE % is displayed in the 30-year financial page.


Pulsion Medical Systems SE  (LTS:0NFX) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2022 )
=Net Income/Total Stockholders Equity
=0.988/23.062
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(0.988 / 29.659)*(29.659 / 32.655)*(32.655 / 23.062)
=Net Margin %*Asset Turnover*Equity Multiplier
=3.33 %*0.9083*1.416
=ROA %*Equity Multiplier
=3.02 %*1.416
=4.28 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2022 )
=Net Income/Total Stockholders Equity
=0.988/23.062
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (0.988 / 7.415) * (7.415 / 7.271) * (7.271 / 29.659) * (29.659 / 32.655) * (32.655 / 23.062)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.1332 * 1.0198 * 24.52 % * 0.9083 * 1.416
=4.28 %

Note: The net income data used here is one times the annual (Dec. 2022) net income data. The Revenue data used here is one times the annual (Dec. 2022) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Pulsion Medical Systems SE ROE % Related Terms

Thank you for viewing the detailed overview of Pulsion Medical Systems SE's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pulsion Medical Systems SE (LTS:0NFX) Business Description

Traded in Other Exchanges
N/A
Address
Hans-Riedl-Street 17, Feldkirchen, DEU, 85622
Pulsion Medical Systems SE operates with its business units hemodynamic monitoring which is engaged in developing, manufacturing, and sale of systems used to monitor, diagnose, and manage physical parameters of patients in intensive care unit, and perfusion imaging which is engaged in developing, manufacturing, and sale of indocyanine green and complementary devices to visualize micro perfusion. The technology developed by the company for critical care are picco, proaqt, limon technology, and eirus technology.

Pulsion Medical Systems SE (LTS:0NFX) Headlines

No Headlines